Deciphera Pharmaceuticals, Inc. (DCPH) has a market capitalization of $2.21B and trades at $25.59. The 52-week range is 9.9-25.61.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -11.2, Earnings Per Share (EPS) of $-2.29, annual revenue of $163.36M.
The stock has a beta of 0.18, operates in the Healthcare sector.
